BOLD
Audentes Therapeutics, Inc
BOLD
BOLD
Delisted
BOLD was delisted on the 14th of January, 2020.
123 hedge funds and large institutions have $1.37B invested in Audentes Therapeutics, Inc in 2018 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 52 increasing their positions, 34 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
123
Holders Change
+9
Holders Change %
+7.89%
% of All Funds
2.82%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
24
Increased
52
Reduced
34
Closed
15
Calls
$2.5M
Puts
$4.19M
Net Calls
-$1.69M
Net Calls Change
-$1.41M
Top Buyers
1 |
RG
Redmile Group
San Francisco,
California
|
$85.2M |
2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
$89.3M |
3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
$32.2M |
4 |
BlackRock
New York
|
$93.9M |
5 |
PHS
PFM Health Sciences
San Francisco,
California
|
$16.3M |